抗病毒-话题@MedSci

#抗病毒#

311篇内容 | 5684人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1292475, encodeId=427f12924e5c6, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Digest Dis Sci: HBV相关肝癌根治后的抗病毒治疗可降低肿瘤复发, objectType=article, longId=161285, objectId=5507161285a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5507161285a1, replyNumber=0, likeNumber=75, createdTime=2019-02-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5507161285a1, moduleTitle=Digest Dis Sci: HBV相关肝癌根治后的抗病毒治疗可降低肿瘤复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5507161285a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292474, encodeId=d5e012924e4d5, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标, objectType=article, longId=160677, objectId=8df71606e764, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df71606e764, replyNumber=0, likeNumber=74, createdTime=2019-02-22, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df71606e764, moduleTitle=J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df71606e764)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292473, encodeId=ec0212924e361, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Lancet：抗病毒治疗对HCV患者临床结局的影响, objectType=article, longId=160028, objectId=342516002873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=342516002873, replyNumber=0, likeNumber=62, createdTime=2019-02-16, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=342516002873, moduleTitle=Lancet：抗病毒治疗对HCV患者临床结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=342516002873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292472, encodeId=56fc12924e23c, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Lancet Gastroen Hepatol：慢性丙型肝炎抗病毒新药临床III期试验研究进展, objectType=article, longId=159965, objectId=41ba15996571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ba15996571, replyNumber=0, likeNumber=67, createdTime=2019-02-15, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ba15996571, moduleTitle=Lancet Gastroen Hepatol：慢性丙型肝炎抗病毒新药临床III期试验研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ba15996571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292471, encodeId=5a7212924e16f, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=2019 PHE指南：应用抗病毒药物治疗和预防季节性流感（v9.1）, objectType=article, longId=159825, objectId=5f95159825e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f95159825e4, replyNumber=0, likeNumber=21, createdTime=2019-02-13, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f95159825e4, moduleTitle=2019 PHE指南：应用抗病毒药物治疗和预防季节性流感（v9.1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f95159825e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292470, encodeId=4ee412924e0b1, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Clin Gastroenterology H：无干扰素抗病毒治疗方案在丙型肝炎病毒相关性冷球蛋白血症血管炎患者中的长期疗效, objectType=article, longId=159759, objectId=2fb5159e59b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fb5159e59b6, replyNumber=0, likeNumber=48, createdTime=2019-02-12, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fb5159e59b6, moduleTitle=Clin Gastroenterology H：无干扰素抗病毒治疗方案在丙型肝炎病毒相关性冷球蛋白血症血管炎患者中的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fb5159e59b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292469, encodeId=436d12924692b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用, objectType=article, longId=159165, objectId=27791591650a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27791591650a, replyNumber=0, likeNumber=81, createdTime=2019-01-31, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27791591650a, moduleTitle=Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27791591650a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292468, encodeId=d0ed12924686f, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径, objectType=article, longId=158896, objectId=a6ad15889681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ad15889681, replyNumber=0, likeNumber=64, createdTime=2019-01-27, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ad15889681, moduleTitle=Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ad15889681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292467, encodeId=e43b129246eda, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Cell Res：舒红兵课题组发文，揭示抗病毒天然免疫新机制, objectType=article, longId=158622, objectId=3eb01586227c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eb01586227c, replyNumber=0, likeNumber=80, createdTime=2019-01-23, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eb01586227c, moduleTitle=Cell Res：舒红兵课题组发文，揭示抗病毒天然免疫新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eb01586227c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292466, encodeId=6865129246643, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Cell Rep：病毒学国家重点实验室刘昱课题组在抗病毒天然免疫方面取得新进展, objectType=article, longId=158557, objectId=a68915855eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a68915855eb4, replyNumber=0, likeNumber=0, createdTime=2019-01-22, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a68915855eb4, moduleTitle=Cell Rep：病毒学国家重点实验室刘昱课题组在抗病毒天然免疫方面取得新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a68915855eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292465, encodeId=5f171292465d1, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, objectType=article, longId=156075, objectId=86e41560e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86e41560e596, replyNumber=0, likeNumber=57, createdTime=2018-12-19, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86e41560e596, moduleTitle=J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86e41560e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292464, encodeId=3fc3129246487, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=AP&T：丙型肝炎病毒患者接受抗病毒治疗对肝硬化患者肠道微生物群的影响, objectType=article, longId=155882, objectId=b5441558826c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5441558826c, replyNumber=0, likeNumber=58, createdTime=2018-12-17, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5441558826c, moduleTitle=AP&T：丙型肝炎病毒患者接受抗病毒治疗对肝硬化患者肠道微生物群的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5441558826c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292463, encodeId=034c129246347, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发, objectType=article, longId=155874, objectId=e0181558e4e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0181558e4e7, replyNumber=0, likeNumber=77, createdTime=2018-12-17, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0181558e4e7, moduleTitle=Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0181558e4e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292462, encodeId=3c931292462fd, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理, objectType=article, longId=154463, objectId=0d6215446319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d6215446319, replyNumber=0, likeNumber=73, createdTime=2018-11-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d6215446319, moduleTitle=惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d6215446319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292461, encodeId=785912924616d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=肝硬化患者的治疗：抗病毒还是抗纤维化？, objectType=article, longId=154154, objectId=4271154154e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4271154154e3, replyNumber=0, likeNumber=98, createdTime=2018-11-23, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4271154154e3, moduleTitle=肝硬化患者的治疗：抗病毒还是抗纤维化？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4271154154e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292460, encodeId=65d1129246098, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=流感季医疗机构须保障抗病毒药物充足, objectType=article, longId=154079, objectId=51011540e92c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51011540e92c, replyNumber=0, likeNumber=70, createdTime=2018-11-23, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51011540e92c, moduleTitle=流感季医疗机构须保障抗病毒药物充足, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51011540e92c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292459, encodeId=dfd812924593c, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Cell Res：武汉大学钟波组在抗病毒天然免疫应答领域取得重要进展, objectType=article, longId=153409, objectId=086915340934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086915340934, replyNumber=0, likeNumber=90, createdTime=2018-11-15, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086915340934, moduleTitle=Cell Res：武汉大学钟波组在抗病毒天然免疫应答领域取得重要进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=086915340934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292458, encodeId=80b3129245861, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, objectType=article, longId=152966, objectId=6bf3152966e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf3152966e3, replyNumber=0, likeNumber=86, createdTime=2018-11-09, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf3152966e3, moduleTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf3152966e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292457, encodeId=9480129245e64, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=骆抗先 | 肝硬化患者的治疗：抗病毒还是抗纤维化？, objectType=article, longId=152716, objectId=f3bd152e168a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3bd152e168a, replyNumber=0, likeNumber=75, createdTime=2018-11-05, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3bd152e168a, moduleTitle=骆抗先 | 肝硬化患者的治疗：抗病毒还是抗纤维化？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3bd152e168a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292456, encodeId=1b151292456f8, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, objectType=article, longId=151478, objectId=14541514e895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14541514e895, replyNumber=0, likeNumber=19, createdTime=2018-10-22, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14541514e895, moduleTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14541514e895)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗病毒

2020-05-29

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Digest Dis Sci: HBV相关肝癌根治后的抗病毒治疗可降低肿瘤复发

2019-02-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标

2019-02-22

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Lancet：抗病毒治疗对HCV患者临床结局的影响

2019-02-16

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Lancet Gastroen Hepatol：慢性丙型肝炎抗病毒新药临床III期试验研究进展

2019-02-15

yahu (审核中...)

前往app查看评论内容

#抗病毒#

2019 PHE指南：应用抗病毒药物治疗和预防季节性流感（v9.1）

2019-02-13

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Clin Gastroenterology H：无干扰素抗病毒治疗方案在丙型肝炎病毒相关性冷球蛋白血症血管炎患者中的长期疗效

2019-02-12

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Sci Rep：ABX464独特的作用机制，同时产生抗炎和抗病毒作用

2019-01-31

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径

2019-01-27

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Cell Res：舒红兵课题组发文，揭示抗病毒天然免疫新机制

2019-01-23

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Cell Rep：病毒学国家重点实验室刘昱课题组在抗病毒天然免疫方面取得新进展

2019-01-22

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Hepatology：直接作用抗病毒药物与干扰素对HCV相关HCC早期复发的影响无差异

2018-12-19

yahu (审核中...)

前往app查看评论内容

#抗病毒#

AP&T：丙型肝炎病毒患者接受抗病毒治疗对肝硬化患者肠道微生物群的影响

2018-12-17

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Ann Surg：抗病毒治疗可降低HBV-DNA水平低的患者的肝细胞癌复发

2018-12-17

yahu (审核中...)

前往app查看评论内容

#抗病毒#

惨痛的代价/慢性乙肝的抗病毒治疗需要规范管理

2018-11-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

肝硬化患者的治疗：抗病毒还是抗纤维化？

2018-11-23

yahu (审核中...)

前往app查看评论内容

#抗病毒#

流感季医疗机构须保障抗病毒药物充足

2018-11-23

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Cell Res：武汉大学钟波组在抗病毒天然免疫应答领域取得重要进展

2018-11-15

yahu (审核中...)

前往app查看评论内容

#抗病毒#

NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）

2018-11-09

yahu (审核中...)

前往app查看评论内容

#抗病毒#

骆抗先 | 肝硬化患者的治疗：抗病毒还是抗纤维化？

2018-11-05

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析

2018-10-22

科室
- - 订阅+
  - 更多科室
工具
服务